HCA Healthcare, Inc. HCA NYSE

HCA Healthcare, Inc. (HCA) generated $12.64B in operating cash flow for fiscal year 2025. After capital expenditures of $4.94B, free cash flow was $7.69B.

Free cash flow margin was 10.2% of revenue. Cash conversion ratio was 1.86x, indicating earnings are backed by cash.

The company returned $679M in dividends and $10.07B in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (25/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (72/100, Pass) — $7.69B (10.2% FCF margin) supports a durable competitive advantage
• INCOME (45/100) — Cash conversion ratio was 1.86x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 61/100 with 5/7 criteria passed.